Jazz Pharmaceuticals plc (JAZZ)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 480 |
| % of all portfolios: | 0.013% |
| Hold Price * : | $240.97 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
21 |
$32,526,775 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 13 May 2025 |
MULLIGAN SEAMUS |
Director |
12 May 2025 |
1,621 |
103.00 |
166,962 |
| 13 May 2025 |
MULLIGAN SEAMUS |
Director |
09 May 2025 |
80,684 |
98.10 |
7,915,472 |
| 13 May 2025 |
MULLIGAN SEAMUS |
Director |
09 May 2025 |
100 |
99.71 |
9,971 |
| 13 May 2025 |
MULLIGAN SEAMUS |
Director |
09 May 2025 |
19,216 |
98.91 |
1,900,678 |
| 05 Mar 2024 |
JOHNSON PHILIP L |
EVP & Chief Financial Officer |
01 Mar 2024 |
12,000 |
119.65 |
1,435,800 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock